)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Definium Therapeutics Inc
Definium Therapeutics Inc (DFTX) investor relations material
Definium Therapeutics Inc AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary11 Jun, 2026
Opening remarks and agenda
Meeting called to order with rules of conduct outlined for orderly proceedings and shareholder participation.
Cautionary note issued regarding forward-looking statements and associated risks.
Executive officers and meeting officials introduced, including CEO, CFO, and Chief Legal Officer.
Quorum confirmed and meeting declared duly constituted for business.
Board and executive committee updates
Seven board nominees, all current directors, were presented for re-election to serve until the next AGM.
No additional director nominations were received within the prescribed timeframe.
Shareholder proposals
Shareholders voted on the election of directors, appointment of auditors, and an amendment to the 2025 Equity Incentive Plan to increase available shares by 5 million.
Clinical and regulatory path for MDD program
Specific use cases for the new equity shares
Board composition and commercialization readiness
EMERGE trial results timing for MDD
2025 Equity Incentive Plan share increase
FDA filing strategy following EMERGE results
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Definium Therapeutics Inc
- Pivotal data for DT120 in GAD and MDD expected soon, with strong durability and remission seen.DFTX
Jefferies Global Healthcare Conference 20265 Jun 2026 - Phase III data for MDD and GAD are imminent, with strong regulatory and commercial readiness.DFTXRBC Capital Markets Global Healthcare Conference 202619 May 2026
- Three pivotal Phase 3 readouts for DT120 ODT expected in 2026, with cash runway into 2028.DFTXQ1 20268 May 2026
- DT120 ODT's late-stage trials target major psychiatric markets with strong efficacy and blockbuster potential.DFTXCorporate presentation7 May 2026
- Virtual meeting to vote on directors, auditor, and equity plan; strong governance and pay practices.DFTXProxy filing27 Apr 2026
- Virtual meeting to vote on directors, auditor, and equity plan share increase.DFTXProxy filing27 Apr 2026
- DT120 ODT advances in phase III for major psychiatric disorders with strong efficacy and launch plans.DFTXInvestor Day 202622 Apr 2026
- Phase III data for DT120 in MDD and GAD could set new standards in psychiatric treatment.DFTX25th Annual Needham Virtual Healthcare Conference16 Apr 2026
- Pivotal phase III data for DT-120 in GAD and MDD expected this year, targeting broad market impact.DFTXStifel 2026 Virtual CNS Forum17 Mar 2026
Next Definium Therapeutics Inc earnings date
Q2 202630 Jul, 2026
Definium Therapeutics Inc
Next Definium Therapeutics Inc earnings date
Q2 202630 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage